NASDAQ:ENDP - Endo International Stock Price, Forecast & News

Endo International trades on the NASDAQ under the ticker symbol "ENDP."

Endo International PLC (NASDAQ:ENDP) issued its earnings results on Monday, November, 4th. The company reported $0.60 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.53 by $0.07. The business earned $729 million during the quarter, compared to analysts' expectations of $709.01 million. Endo International had a negative return on equity of 99.08% and a negative net margin of 16.89%. The business's revenue for the quarter was down 2.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.71 EPS. View Endo International's Earnings History.

Endo International is scheduled to release their next quarterly earnings announcement on Thursday, February 27th 2020. View Earnings Estimates for Endo International.

Endo International updated its FY19 earnings guidance on Monday, November, 4th. The company provided earnings per share (EPS) guidance of $2.10-2.25 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.16. The company issued revenue guidance of $2.86-2.89 billion, compared to the consensus revenue estimate of $2.86 billion.

13 Wall Street analysts have issued twelve-month target prices for Endo International's shares. Their forecasts range from $2.00 to $15.00. On average, they expect Endo International's stock price to reach $7.38 in the next year. This suggests a possible upside of 11.8% from the stock's current price. View Analyst Price Targets for Endo International.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Endo International in the last year. There are currently 2 sell ratings, 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Endo International.

News headlines about ENDP stock have trended very positive recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Endo International earned a news sentiment score of 3.9 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near term. View News Stories for Endo International.

Endo International saw a drop in short interest in December. As of December 31st, there was short interest totalling 31,730,000 shares, a drop of 5.6% from the December 15th total of 33,620,000 shares. Based on an average daily trading volume, of 7,940,000 shares, the days-to-cover ratio is presently 4.0 days. Currently, 15.6% of the shares of the company are short sold. View Endo International's Current Options Chain.

Some companies that are related to Endo International include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Horizon Therapeutics (HZNP), The Medicines (MDCO), Nektar Therapeutics (NKTR) and Zogenix (ZGNX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Endo International investors own include Bausch Health Companies (BHC), TherapeuticsMD (TXMD), Teva Pharmaceutical Industries (TEVA), Cleveland-Cliffs (CLF), Mallinckrodt (MNK), Gilead Sciences (GILD), Micron Technology (MU), Advanced Micro Devices (AMD), NVIDIA (NVDA) and Bank of America (BAC).

Endo International's stock is owned by a number of of institutional and retail investors. Top institutional investors include Nisa Investment Advisors LLC (0.01%). Company insiders that own Endo International stock include Nancy J Hutson, Roger H Kimmel and William P Montague. View Institutional Ownership Trends for Endo International.

ENDP stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC. View Insider Buying and Selling for Endo International.

Shares of ENDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ENDP stock can currently be purchased for approximately $6.60.

Endo International has a market capitalization of $1.50 billion and generates $2.95 billion in revenue each year. The company earns $-1,031,470,000.00 in net income (profit) each year or $2.89 on an earnings per share basis. Endo International employs 2,910 workers across the globe.View Additional Information About Endo International.

The official website for Endo International is http://www.endo.com/.

Endo International's mailing address is First Floor Minerva House Simmonscourt Road Ballsbridge, Dublin L2, 19355. The company can be reached via phone at 011-353-1268-2000 or via email at [email protected]